The long-term objective of this proposal is to develop broadly applicable methods to utilize engineered nucleases to facilitate gene targeting in human somatic and pluripotent cells.
The specific aims are: 1) to enhance our ability to genetically engineer all types of genetic modifications by homologous recombination using engineered nucleases (TAL effector nucleases or TALENs) in human somatic and pluripotent cells and 2) to improve our ability to use TALEN-derived nicking enzymes for homologous recombination. This proposal will leverage a high-throughput assembly method for creating engineered TALENs and apply it to the genetic engineering of human cell lines. Successful development of the proposed methods for introducing small insertions and single-base modifications to the human genome will enhance the ability to systematically investigate the relationship between human gene variation and function and enable genetic manipulations that have been previously limited to mouse model systems.
Gene targeting by homologous recombination is a powerful tool that has been used extensively to create gene targeted mouse models of human disease. Aided by recent advances in engineered nuclease technology, this proposal seeks to develop broadly applicable methods that would enable the routine use of gene targeting in human somatic and pluripotent cells (and other cell types) to create relevant disease models, to functionally interrogate and study genetic variants in relation to human disease, and to genetically engineer safer cells for clinical therapeutic applications.
|Wyvekens, Nicolas; Tsai, Shengdar Q; Joung, J Keith (2015) Genome Editing in Human Cells Using CRISPR/Cas Nucleases. Curr Protoc Mol Biol 112:31.3.1-18|
|Wyvekens, Nicolas; Topkar, Ved V; Khayter, Cyd et al. (2015) Dimeric CRISPR RNA-Guided FokI-dCas9 Nucleases Directed by Truncated gRNAs for Highly Specific Genome Editing. Hum Gene Ther 26:425-31|
|Hubbard, Basil P; Badran, Ahmed H; Zuris, John A et al. (2015) Continuous directed evolution of DNA-binding proteins to improve TALEN specificity. Nat Methods 12:939-42|
|Tsai, Shengdar Q; Zheng, Zongli; Nguyen, Nhu T et al. (2015) GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases. Nat Biotechnol 33:187-97|
|Low, Benjamin E; Krebs, Mark P; Joung, J Keith et al. (2014) Correction of the Crb1rd8 allele and retinal phenotype in C57BL/6N mice via TALEN-mediated homology-directed repair. Invest Ophthalmol Vis Sci 55:387-95|
|Tsai, Shengdar Q; Wyvekens, Nicolas; Khayter, Cyd et al. (2014) Dimeric CRISPR RNA-guided FokI nucleases for highly specific genome editing. Nat Biotechnol 32:569-76|
|Maeder, Morgan L; Angstman, James F; Richardson, Marcy E et al. (2013) Targeted DNA demethylation and activation of endogenous genes using programmable TALE-TET1 fusion proteins. Nat Biotechnol 31:1137-42|
|Hwang, Woong Y; Fu, Yanfang; Reyon, Deepak et al. (2013) Efficient genome editing in zebrafish using a CRISPR-Cas system. Nat Biotechnol 31:227-9|
|Cade, Lindsay; Reyon, Deepak; Hwang, Woong Y et al. (2012) Highly efficient generation of heritable zebrafish gene mutations using homo- and heterodimeric TALENs. Nucleic Acids Res 40:8001-10|